The Endothelial Glycocalyx and Retinal Hemodynamics.
endothelial glycocalyx
heparinase
hyaluronidase
microhematocrit
retinal hemodynamics
Journal
Pathophysiology : the official journal of the International Society for Pathophysiology
ISSN: 1873-149X
Titre abrégé: Pathophysiology
Pays: Switzerland
ID NLM: 9433813
Informations de publication
Date de publication:
17 Dec 2022
17 Dec 2022
Historique:
received:
16
09
2022
revised:
20
10
2022
accepted:
14
12
2022
entrez:
22
12
2022
pubmed:
23
12
2022
medline:
23
12
2022
Statut:
epublish
Résumé
Previous studies suggest that the endothelial glycocalyx adds to vascular resistance, inhibits thrombosis, and is critical for regulating homogeneous blood flow and ensuring uniform red blood cell (RBC) distribution. However, these functions and consequences of the glycocalyx have not been examined in the retina. We hypothesize that the endothelial glycocalyx is a critical regulator of retinal hemodynamics and perfusion and decreases the propensity for retinal thrombus formation. Hyaluronidase and heparinase, which are endothelial glycocalyx-degrading enzymes, were infused into mice. Fluorescein isothiocyanate-dextran (2000 kDa) was injected to measure lumen diameter, while RBC velocity and distribution were measured using fluorescently labeled RBCs. The diameters and velocities were used to calculate retinal blood flow and shear rates. Mean circulation time was calculated by measuring the difference between arteriolar and venular mean transit times. Rose Bengal dye was infused, followed by illumination with a green light to induce thrombosis. The acute infusion of hyaluronidase and heparinase led to significant increases in both arteriolar (7%) and venular (16%) diameters in the retina, with a tendency towards increased arteriolar velocity. In addition, the degradation caused a significant decrease in the venular shear rate (14%). The enzyme infusion resulted in substantial increases in total retinal blood flow (26%) and retinal microhematocrit but no changes in the mean circulation time through the retina. We also observed an enhanced propensity for retinal thrombus formation with the removal of the glycocalyx. Our data suggest that acute degradation of the glycocalyx can cause significant changes in retinal hemodynamics, with increases in vessel diameter, blood flow, microhematocrit, pro-thrombotic conditions, and decreases in venular shear rate.
Identifiants
pubmed: 36548208
pii: pathophysiology29040052
doi: 10.3390/pathophysiology29040052
pmc: PMC9785437
doi:
Types de publication
Journal Article
Langues
eng
Pagination
663-677Subventions
Organisme : NEI NIH HHS
ID : R01 EY025632
Pays : United States
Organisme : NIH HHS
ID : EY025632
Pays : United States
Organisme : Center for Cardiovascular Diseases and Science (CCDS), Louisiana State University Health Sciences Center-Shreveport
ID : None
Références
Curr Opin Pharmacol. 2019 Apr;45:66-71
pubmed: 31112922
Am J Physiol. 1990 Mar;258(3 Pt 2):H647-54
pubmed: 2316679
Pflugers Arch. 2007 Jun;454(3):345-59
pubmed: 17256154
Exp Eye Res. 2010 Nov;91(5):670-5
pubmed: 20727883
Microvasc Res. 1974 Jan;7(1):131-43
pubmed: 4821168
Exp Eye Res. 2008 Mar;86(3):528-36
pubmed: 18262522
Front Cell Dev Biol. 2021 Aug 31;9:734276
pubmed: 34532323
Matrix Biol Plus. 2021 Oct 21;12:100087
pubmed: 34820618
Microcirculation. 2002 Jul;9(3):189-96
pubmed: 12080416
Acta Med Okayama. 2010 Oct;64(5):277-83
pubmed: 20975760
Exp Eye Res. 2012 May;98:9-15
pubmed: 22440813
Glycobiology. 2022 Jul 13;32(8):720-734
pubmed: 35552402
Am J Physiol Heart Circ Physiol. 2001 Mar;280(3):H1051-7
pubmed: 11179046
Am J Physiol Heart Circ Physiol. 2016 Jul 1;311(1):H168-76
pubmed: 27199117
J Appl Physiol (1985). 2007 Jun;102(6):2251-9
pubmed: 17347383
Am J Physiol. 1997 Nov;273(5):H2272-9
pubmed: 9374763
Indian J Anaesth. 2019 Jan;63(1):6-14
pubmed: 30745606
Am J Physiol Heart Circ Physiol. 2007 Aug;293(2):H1023-30
pubmed: 17468337
J Vis Exp. 2013 Jun 09;(76):
pubmed: 23770844
Am J Physiol. 1993 May;264(5 Pt 2):H1504-8
pubmed: 7684574
Biomech Model Mechanobiol. 2013 Jan;12(1):111-21
pubmed: 22411016
Cardiovasc Res. 1971 Jul;5(3):406-12
pubmed: 5558737
Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7988-95
pubmed: 12810946
Circ Res. 1996 Sep;79(3):581-9
pubmed: 8781491
Biomicrofluidics. 2014 Jan 29;8(1):014104
pubmed: 24753725
Exp Eye Res. 2009 Jan;88(1):106-12
pubmed: 18996116
Biorheology. 2019;56(2-3):181-189
pubmed: 30958328
Am J Physiol Gastrointest Liver Physiol. 2003 Jan;284(1):G123-9
pubmed: 12388188
FASEB J. 2019 Dec;33(12):13346-13357
pubmed: 31545913
Prog Retin Eye Res. 2012 Sep;31(5):377-406
pubmed: 22580107
Invest Ophthalmol Vis Sci. 2003 Nov;44(11):4960-7
pubmed: 14578423
Am J Physiol Heart Circ Physiol. 2005 Dec;289(6):H2657-64
pubmed: 16040719
Am J Physiol Heart Circ Physiol. 2002 Oct;283(4):H1282-91
pubmed: 12234777
Invest Ophthalmol Vis Sci. 2013 Apr 26;54(4):2992-9
pubmed: 23572104
Proc Natl Acad Sci U S A. 2014 Dec 2;111(48):17308-13
pubmed: 25404299
Cardiovasc Eng Technol. 2021 Feb;12(1):37-71
pubmed: 32959164
Invest Ophthalmol Vis Sci. 2020 Aug 3;61(10):12
pubmed: 32761138
J Vis Exp. 2015 Jun 23;(100):e52794
pubmed: 26131664
Compr Physiol. 2020 Jul 8;10(3):933-974
pubmed: 32941691
Exp Eye Res. 2021 Dec;213:108846
pubmed: 34801534
Physiol Res. 2018 Mar 16;67(1):41-44
pubmed: 29137486
J Biomech. 2008 Aug 28;41(12):2726-34
pubmed: 18656200
Circulation. 2000 Apr 4;101(13):1500-2
pubmed: 10747340
Sci Rep. 2021 May 31;11(1):11386
pubmed: 34059731
Diabetologia. 2010 Dec;53(12):2646-55
pubmed: 20865240
Exp Eye Res. 2019 Feb;179:125-131
pubmed: 30445048